Product Information
MECLIZINE 12.5 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.0464 per EA under NDC 16571066001. Its NADAC has been published 318 times since May 27, 2020.
The High Outlier badge above means this manufacturer's average price in the Meclizine Hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
12.5 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
16571066001
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
MECLIZINE HYDROCHLORIDEApproval Type
Authorized Generic (NDA)
FDA Application
NDA010721On Market Since
1/15/2020
Pharmacological Classes
Price Statistics
The NADAC for MECLIZINE 12.5 MG TABLET has been published 318 times since May 27, 2020, and over the history we have for it it has declined 70.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0464 per EA |
|---|---|
| All-time high | $0.1668 (Jul 15, 2020) |
| All-time low | $0.0418 (Nov 20, 2024) |
| 52-week high | $0.0535 |
| 52-week low | $0.0461 |
| Median price | $0.0720 |
| Average price | $0.0825 |
| Largest weekly change | -29.2% (Nov 20, 2024) |
| Weeks tracked | 318 |
| Tracking since | May 27, 2020 |
Generic Alternatives
The matcher finds 8 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 8 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 33% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of MECLIZINE 12.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for MECLIZINE 12.5 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $0.0464 per EA (NDC 16571066001), effective Jun 24, 2026.
How has the price of MECLIZINE 12.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for MECLIZINE 12.5 MG TABLET has declined 70.4%. It has been tracked across 318 weekly CMS publications since May 27, 2020.
What are the highest and lowest recorded NADAC prices for MECLIZINE 12.5 MG TABLET?
Since May 27, 2020, the NADAC for MECLIZINE 12.5 MG TABLET has ranged from a low of $0.0418 (Nov 20, 2024) to a high of $0.1668 (Jul 15, 2020), with a median of $0.0720 per EA.
Are there cheaper alternatives to MECLIZINE 12.5 MG TABLET?
Yes. 8 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, MECLIZINE 12.5 MG TABLET, is $0.0309 per EA — about 33% below MECLIZINE 12.5 MG TABLET.
Who manufactures MECLIZINE 12.5 MG TABLET?
MECLIZINE 12.5 MG TABLET (NDC 16571066001) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification